Clin Endosc.  2014 Nov;47(6):538-543. 10.5946/ce.2014.47.6.538.

Gastric Endoscopic Submucosal Dissection Is Safe for Day Patients

• Ahn SY
• Jang SI
• Lee DW
• Jeon SW

• KMID: 2134492
• DOI: http://doi.org/10.5946/ce.2014.47.6.538

Abstract

BACKGROUND/AIMS
Although the advantages of endoscopic submucosal dissection (ESD) are well established, there are important limitations that relate to its higher cost and higher rate of complications compared with endoscopic mucosal resection. This study assessed the therapeutic safety and efficacy of ESD in the treatment of small gastric dysplasia and early gastric cancer (EGC) located within the antrum in an outpatient setting, and it compared the results with those from patients admitted to hospital for ESD treatment.
METHODS
This study was a retrospective analysis of a prospectively maintained database. We reviewed consecutive patients with EGC or gastric dysplasia who underwent ESD between October 2007 and May 2008. The lesions were smaller than 2 cm and were located in the antrum. We analyzed 105 lesions in 105 patients. The patients were assigned to two groups according to each patient's preference.
RESULTS
The overall rates of complete resection were 98.1% in the inpatients group and 94.3% in the outpatients group. Immediate bleeding occurred in four inpatients, which included one patient in the outpatient group. Delayed bleeding occurred in one inpatient within 24 hours of the procedure. Macroperforations did not occur in either group. A microperforation was found in one outpatient.
CONCLUSIONS
The safety and efficacy of ESD used to treat small gastric tumors in the antrum in an outpatient setting appeared to be similar to the safety and efficacy of ESD used to treat patients who were admitted to the hospital.

Keyword

Endoscopic submucosal dissection; Hemorrhage; Perforation; Outpatients

MeSH Terms

Hemorrhage
Humans
Inpatients
Outpatients
Prospective Studies
Retrospective Studies
Stomach Neoplasms

Reference

1. Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006; 41:929–942. PMID: 17096062.

2. Chung IK, Lee JH, Lee SH, et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc. 2009; 69:1228–1235. PMID: 19249769.

3. Gotoda T. A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer. Clin Gastroenterol Hepatol. 2005; 3(7 Suppl 1):S71–S73. PMID: 16013003.

4. Messmann H, Probst A. Management of endoscopic submucosal dissection complications. Endoscopy. 2009; 41:712–714. PMID: 19670140.

5. Sugimoto T, Okamoto M, Mitsuno Y, et al. Endoscopic submucosal dissection is an effective and safe therapy for early gastric neoplasms: a multicenter feasible study. J Clin Gastroenterol. 2012; 46:124–129. PMID: 21959325.

6. Japanese Gastric Cancer AssociationJapanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14:101–112. PMID: 21573743.

7. Jeon SW, Jung MK, Cho CM, et al. Predictors of immediate bleeding during endoscopic submucosal dissection in gastric lesions. Surg Endosc. 2009; 23:1974–1979. PMID: 18553202.

8. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001; 48:225–229. PMID: 11156645.

9. Conio M, Ponchon T, Blanchi S, Filiberti R. Endoscopic mucosal resection. Am J Gastroenterol. 2006; 101:653–663. PMID: 16464227.

10. Jung MK, Jeon SW, Cho CM, et al. Hyperglycaemia, hypercholesterolaemia and the risk for developing gastric dysplasia. Dig Liver Dis. 2008; 40:361–365. PMID: 18291734.

11. Oka S, Tanaka S, Kaneko I, et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006; 64:877–883. PMID: 17140890.

12. Mukai S, Cho S, Kotachi T, et al. Analysis of delayed bleeding after endoscopic submucosal dissection for gastric epithelial neoplasms. Gastroenterol Res Pract. 2012; 2012:875323. PMID: 22536221.

13. Higashiyama M, Oka S, Tanaka S, et al. Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc. 2011; 23:290–295. PMID: 21951088.

14. Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009; 58:331–336. PMID: 19001058.

15. Minami S, Gotoda T, Ono H, Oda I, Hamanaka H. Complete endoscopic closure of gastric perforation induced by endoscopic resection of early gastric cancer using endoclips can prevent surgery (with video). Gastrointest Endosc. 2006; 63:596–601. PMID: 16564858.

16. Abe Y, Inamori M, Iida H, et al. Clinical characteristics of patients with gastric perforation following endoscopic submucosal resection for gastric cancer. Hepatogastroenterology. 2009; 56:921–924. PMID: 19621730.

17. Kiriyama S, Oda I, Nishimoto F, Mashimo Y, Ikehara H, Gotoda T. Pilot study to assess the safety of local lidocaine injections during endoscopic submucosal dissection for early gastric cancer. Gastric Cancer. 2009; 12:142–147. PMID: 19890693.

18. Choi HS, Kim KO, Chun HJ, et al. The efficacy of transdermal fentanyl for pain relief after endoscopic submucosal dissection: a prospective, randomised controlled trial. Dig Liver Dis. 2012; 44:925–929. PMID: 22824834.

19. Kakushima N, Fujishiro M, Kodashima S, Muraki Y, Tateishi A, Omata M. A learning curve for endoscopic submucosal dissection of gastric epithelial neoplasms. Endoscopy. 2006; 38:991–995. PMID: 17058163.

20. Gotoda T, Friedland S, Hamanaka H, Soetikno R. A learning curve for advanced endoscopic resection. Gastrointest Endosc. 2005; 62:866–867. PMID: 16301027.